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Abstract
Massively parallel pyrosequencing is a high-throughput technology that can sequence hundreds of
thousands of DNA/RNA fragments in a single experiment. Combining it with immunoprecipitation-
based biochemical assays, such as cross-linking immunoprecipitation (CLIP), provides a genome-
wide method to detect the sites at which proteins bind DNA or RNA. In a CLIP-pyrosequencing
experiment, the resolutions of the detected protein binding regions are partially determined by the
length of the detected RNA fragments (CLIP amplicons) after trimming by RNase digestion. The
lengths of these fragments usually range from 50-70 nucleotides. Many genomic regions are marked
by multiple RNA fragments. In this paper, we report an empirical approach to refine the localization
of protein binding regions by using the distribution pattern of the detected RNA fragments and the
sequence specificity of RNase digestion. We present two regions to which multiple amplicons map
as examples to demonstrate this approach.
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Introduction
RNA-protein interactions influence virtually every step of
post-transcriptional gene expression including pre-mRNA
capping, splicing, polyadenylation and mRNA export, sta-
bility, localization and translation [1]. These reactions are
not only essential steps in the expression of most eukary-
otic genes, but also provide key points for the regulation
of gene expression and may even increase the proteomic
complexity encoded by a genome [2]. The human genome
encodes at least 673 genes with predicted RNA binding
activity (GO:00003723, http://www.ensembl.org/
biomart). Mutations disrupting function of either cis-act-
ing RNA elements or trans-acting RNA binding proteins
(RBP) form the basis for many heritable human diseases
[3-5]. Despite the profound impact of RNA binding pro-
teins on cellular metabolism, we still know little regarding
the RNA binding specificity of these important factors.
The analysis of RNA binding proteins is further compli-
cated by the observation that many are multifunctional
[1]. Elucidating the functions of RNA binding proteins
require detailed biochemical analyses, and are constantly
challenged as novel biological roles for these proteins are
described; this process is usually slow. A more effective
method to understand the roles of RNA binding proteins
in RNA processing is to allow the specificity of RNA-pro-
tein interactions to establish connections with mRNA or
ncRNA (non-coding RNA) metabolism. Thus truly unbi-
ased, genome-wide methods capable of preserving the in
situ RNA binding specificity are required to elucidate the
functions of RNA binding proteins in an efficient and
comprehensive manner.
The most widely used technique for studying the interac-
tions of RNA binding proteins with their RNA targets in
vivo may be the immunoprecipitation (IP)-microarray
assay [4,5]. RNA binding proteins are immunoprecipi-
tated from cultured cells or tissues and co-purifying RNA
is used to probe expression arrays. However, under these
conditions RNA binding proteins are free to dissociate
from their endogenous RNA targets and re-associate with
higher affinity binding sites, thus there is great risk of false
discovery [6]. The cross-linking immunoprecipitaion
(CLIP) assay can overcome these drawbacks while facili-
tating identification of RNA targets [7,8]. CLIP analysis
has been successfully used to study the murine RNA bind-
ing protein NOVA, and also reveal the specific binding
sites within the captured pre-mRNAs [7,8].
In order to conduct global profiling of the RNA sites
bound by RNA binding proteins in vivo, we have coupled
the CLIP purification strategy from with high-throughput
pyrosequencing of CLIP amplicons; we call this pyro-CLIP
technology (pCLIP). The 454 sequencing platform (454
Life Sciences, Branford, CT) is an integrated system of
emulsion-based PCR amplification of hundreds of thou-
sands of DNA/RNA fragments linked to high throughput
parallel pyrosequencing in picoliter-sized wells [9-11].
Pyrosequencing allows for comprehensive sequencing of
the CLIP amplicon pool and is extremely cost-effective rel-
ative to Sanger sequencing.
Pyro-CLIP experiments generate hundreds of thousands
of RNA fragments (CLIP amplicons) to which an RBP
binds. Substantial bioinformatics analysis is required to
accurately identify the protein binding regions genome-
wide. When the experimentally-detected RNA fragments
(CLIP amplicons) are aligned to the human genome,
many regions are observed to be encompassed by multi-
ple fragments. In this study, we developed an empirical
approach to refine the detection of protein binding
regions by using the distribution pattern of the detected
RNA fragments and the sequence specificity of RNase
digestion along the amplicon-enriched genomic region.
Methods
Data Structure
Pyro-CLIP experiments result in hundreds of thousands of
amplicons (RNA sequences with 50 to 70-bp in length).
Preliminary data suggested that in a pyro-CLIP experi-
ment, dozens of amplicons were usually detected within
one genomic region. Hypothetically, all the detected
amplicons should encompass at least one cis-acting ele-
ment recognized by the studied RNA binding protein. The
number of detected amplicons in each genomic region
depends on various factors including the abundances of
RNA transcript. Fig. 1A depicts a schematic view of this
problem. Intuitively, all the red amplicons will be
detected in the pyro-CLIP experiment since their
sequences encompass the protein binding sites. On the
contrary, no blue sequences are visible because they were
not cross-linked to the RNA-protein complex, and there-
fore will not be immunoprecipitated by the antibody.
In the preliminary data, we found that the distribution of
detected amplicons in each genomic region is similar to
the pattern shown in Fig. 1B. This clearly indicates that the
partial RNase digestion trimmed RNA fragments in a
sequence-specific manner [12]. This feature allows us to
refine the detection of protein binding regions from pyro-
sequencing-derived RNA fragments. In this study, we pro-
pose a computational approach to achieve this goal by
using two types of information, the detected pattern of
RNA amplicons (Fig. 1B), and the estimated specificity of
RNase digestion along the genomic sequence.
The overall procedure includes three key steps: (1) pre-
processing of CLIP amplicons, (2) estimation of sequence
specificity of RNase digestion, and (3) prediction of RNA
binding regions.BMC Genomics 2008, 9(Suppl 1):S17 http://www.biomedcentral.com/1471-2164/9/S1/S17
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Pre-processing of CLIP amplicons
In the pyro-CLIP experiment, two short RNA linker
sequences were ligated on both 5′- and 3′-end of each
amplicon. These linker sequences were used as nested
primer binding sites for reverse transcription and amplifi-
cation. After removing both 5′- and 3′-end linker
sequences, the remaining amplicons were mapped back
into human genome using blastn program [13]. In the
remaining analysis, we only focus on the genomic regions
that contain multiple amplicons.
In practice, the number of genomic regions that match
with the query amplicon varies depending on the selec-
tion of parameters while using the blastn program [13].
We removed all the genomic regions whose length fell out
of 50 to 70-bp range. We also removed the amplicons that
match more than 20 different genomic locations, which
are from repetitive sequences and can't be mapped
uniquely.
Estimation of the sequence specificity of RNase digestion
In the pyro-CLIP assay, RNase digestion was used to trim
the cross-linked RNA fragments to 50-70 nucleotides.
Instead of cutting RNA fragments at random locations,
RNase digestion has sequence specificity. The RNases used
in the experiment were RNase I and RNase T1 (Applied
Biosystems, Foster City, CA).
After mapping the detected amplicons back to the
genome, we observed a large number of RNA fragments
that shared identical 5′- and 3′-end genomic locations as
in Fig 1B, rather than overlapping a site with in a ragged
pattern as in Fig. 1A. This is a strong indication that RNase
prefers to digest RNA sequences at some specific
sequences. In this study, we estimated sequence specifici-
ties of RNase digestion on all possible 6-bp motifs.
Each detected amplicon was generated by two RNase
digestion sites (Fig. 2). After mapping back into the
human genome, the two RNase digestion sites on each
amplicon can be easily determined by combining 3-bp
sequences on both edges of the amplicon (red Ns in Fig.
2), and their natural extensions in the local genomic
region (blue Ns in Fig. 2). We calculated the number of
cutting events on each of 46=4096 potential 6-bp motifs
based on all the detected amplicons and their mapped
genomic locations.
The distribution of 6 nt sequences in the human transcrip-
tome is not random, so in order to estimate sequence spe-
Distribution of detected amplicons in the pyro-CLIP experiment Figure 1
Distribution of detected amplicons in the pyro-CLIP experiment. A. Detected and undetected sequence fragments. 
B. Distribution of detected amplicons in the experiment.BMC Genomics 2008, 9(Suppl 1):S17 http://www.biomedcentral.com/1471-2164/9/S1/S17
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cificity of RNase digestion, the number of cutting events
on each 6-bp motif should be corrected based on the fre-
quency of the site. For instance, all the motifs that contain
a CpG di-nucleotide appear in a much lower frequency
than the ones without. Therefore, a lower number of
detected cutting events on these motifs do not necessarily
imply a low sequence specificity of RNase digestion.
Based on this principle, we estimated the likelihood of
RNase digestion on each 6-bp motif by normalizing the
number of detected cutting events to the frequency of
occurrence of the motif in the human transcriptome:
where Lk depicts the likelihood of RNase digestion on the
k-th 6-bp motif; fi denotes the number of cutting events
detected on the i-th 6-bp motif; and f0i represents its fre-
quency of occurrences in the human transcriptome
(N=4096 is the total number of potential 6-bp motifs).
Refining the detection of protein binding regions
The size of detected amplicons ranges from 50 to 70
nucleotides. If there were no sequence specificity to the
RNase digestion, the overlapped pattern of multiple
amplicons would provide very good resolution of the
detection of protein binding (Fig. 1A). However, in many
circumstances, the pattern of amplicons we observed is
more similar to Fig. 1B, or even Fig. 3C, suggesting bias
due to sequence specificity of RNase digestion. We report
an empirical approach to improve the resolution of bind-
ing regions using the likelihood of RNase digestion (esti-
mated in Eq. 1) within local genomic regions.
Our strategy is based on several assumptions:
1) All the detected amplicons should encompass the cis-
acting element to which the protein binds;
2) The probability of each being selected as an RNase
digestion site is proportional to the estimated likelihood
of RNase digestion on its 6-bp motif, calculated in Eq. 1;
3) Each genomic region where multiple amplicons are
detected is located within one RNA transcript;
For each genomic region in which multiple amplicons are
detected, we simulate the distribution of amplicons that
would occur based upon RNase sequence specificity, and
then simulate the subset that would be selected if a pro-
tein bound to a specific site. This simulation is repeated as
the binding site is moved along the RNA. We then com-
pare the distribution of experimentally-detected ampli-
cons (Fig. 3A) and of simulated amplicons (Fig. 3B); the
genomic region resulting with highest similarity was
regarded as the protein binding region. In brief, the pro-
posed empirical approach includes the following steps:
1) Randomly generate a large number of RNA fragments
based on the estimated likelihood of RNase digestion
(Eq.1) along the genomic region in which multiple ampli-
cons were detected plus a 70-bp extension towards both
5′- and 3′-side (Fig. 3B).
2) For each possible protein binding site (i), randomly
select M simulated amplicons from among the RNA frag-
ments generated in the previous step that encompass the
current site (i).  M is the number of experimentally-
detected amplicons (Fig. 3A).
3) For each genomic locus j within the searching region,
calculate the number of encompassing amplicons assum-
ing protein binding occurs at the i-th locus, defined as
F(i,j), in both experimentally-determined group and sim-
ulated group; for each group, F(i) is a vector whose
number of elements is equal to the length of genomic
region being searched.
4) Calculate the Pearson correlation coefficient of the
resultant  F(i) vector between experimentally-detected
Lk
fk f k






Estimation of the sequence specificity of RNase digestion Figure 2
Estimation of the sequence specificity of RNase digestion.BMC Genomics 2008, 9(Suppl 1):S17 http://www.biomedcentral.com/1471-2164/9/S1/S17
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amplicons and simulated amplicons assuming that the
protein binds on the i-th genomic locus, C(i).
5) Continue steps 2 to 4 for the entire region. The region
that results in highest correlation coefficient will be
regarded as the region with the highest binding probabil-
ity.
Evaluation of the effects of various biological variations on 
binding site prediction
In order to evaluate the robustness of the proposed
approach to various noises resulted from multiple biolog-
ical and computational steps, we created a simulated sets
of virtual amplicons based on the sequences of a ran-
domly-selected RNA region, and a pre-defined protein
binding site. While generating these testing data, we delib-
erately included noises from various sources, including:
1) Antibody non-specificity;
2) Inaccurate estimation of the likelihood of RNase diges-
tion on different 6-bp motifs;
3) Noises associating with BLAST search.
We tested the performance of the proposed approach
under different levels of measurement noise based on the
capability of the model to predict the pre-defined protein
binding site.
Searching strategy. Figure 3
Searching strategy. A. Distribution of detected amplicons in the experiment. B. Distribution of detected amplicons in the 
simulation.BMC Genomics 2008, 9(Suppl 1):S17 http://www.biomedcentral.com/1471-2164/9/S1/S17
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Results
Estimation of the sequence specificity on RNase digestion
In the preliminary dataset (unpublished data), a total of
29,071 RNA fragments ranging from 50-70 bp in length
were used to estimate the sequence specificity of RNase
digestion. We calculated the number of occurrences of all
the potential 6–bp motifs at both ends of the RNA frag-
ments, totaling 58,142 6-bp elements. We observed sig-
nificant preference of RNase digestion on some 6-bp
motifs. Only 967 of the 4,096 potential 6-bp motifs
(24%) were observed as digestion sites. Strikingly, 26% of
RNase digestion occurs at AATAAA sites. Fig. 4 demon-
strates the histogram of the cutting frequencies on all the
6-bp motifs that have at least one cutting event. The top
1% are listed in Table 1. To quantitatively evaluate the
sequence specificity of RNase digestion, we calculated the
entropy of RNase cutting frequency at all the potential 6-
bp motifs: E=-Σ(pi*logNpi), where pi is the probability that
6-bp motif i is selected as cutting site pi=fi/ Σfi. By defini-
tion, the resultant entropy should be a number from 0 to
1. A larger entropy implies less sequence specificity of the
RNase digestion. The entropy for the frequencies of
enzyme digestion on 6-bp motif is 0.42. This suggests that
RNase digestion has significant preference for certain
motifs. This finding is different from the reported cleavage
specificity by the manufacturer, where RNase A cleaves at
3′ of single strand C's and U's, and RNase T1 cleaves at 3′
of single strand G's (http://www.ambion.com).
In vertebrate genomes, some sequences appear less fre-
quently than others. For example, the number of occur-
rences of motifs that contain a CpG dinucleotide is
significantly reduced. Therefore, we calculated the fre-
quencies of all the 6-bp motifs in human transcriptome,
and further estimated the likelihood of RNase digestion
on each potential 6-bp motif based on Eq. 1. With this
adjustment, the entropy level of cutting likelihood
becomes 0.56. Top 1% 6-bp motifs with highest cutting
likelihood are listed in Table 1.
Histogram of the estimated likelihood of RNase digestion on 967 6-bp motifs that occur at least once on the  edge of the experimentally detected RNA fragments Figure 4
Histogram of the estimated likelihood of RNase digestion on 967 6-bp motifs that occur at least once on the 
edge of the experimentally detected RNA fragments.BMC Genomics 2008, 9(Suppl 1):S17 http://www.biomedcentral.com/1471-2164/9/S1/S17
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Estimation of binding sites of RNA-binding protein
The 29,071 RNA fragments cover 52 non-overlapping
genomic regions that contain at least 10 fragments. Most
enriched regions contain one or two protein binding sites.
In this report, we use two examples to demonstrate the
potential application of the proposed approach.
1) Genomic regions that contain one protein binding site
One enriched region on chr4: 77,026,287-77,026,348
contains 20 identical RNA fragments (Fig. 5C). This is in
the second intron of PPEF2 (Protein phosphatase EF-hand
calcium-binding domain 2).
We generated a distribution of RNA fragments based on
the likelihood of RNase digestion along the local chromo-
somal region (with an extension of 70-bp in both 5′- and
3′-ends; Eq. 1 and Fig. 5A). For each potential binding site
in the region, we selected 20 virtual RNA fragments that
encompass the assumed binding site. The correlation of
distribution pattern between experimentally-determined
fragments (Fig. 5C) and simulated fragments (Fig. 5D)
was calculated (Fig. 5B). Within this enriched region, it is
clear that the putative binding sites within the first 36-bp
have higher correlation coefficients (all above 96%) with
the actual data than did other binding site candidates. Fig.
5D demonstrates the distribution of simulated RNA frag-
ments by assuming protein binds at the location that has
the highest correlation coefficient (marked with blue
ellipse). Using the same approach on several regions, the
resolution of the binding region could be improved by
over 70%.
2) Genomic regions that contain two protein binding sites
The proposed approach can also be used to refine the
detection of protein binding regions that contain two or
more binding sites. Instead of searching for the position
of one binding site, as shown in Fig. 3B, positions of two
or more putative sites will be optimized to achieve similar
pattern distribution between simulated amplicons and
experimentally-detected amplicons. This will increase the
dimension of searching space.
One example of two-binding-site region, located in the
first intron of gene MRPL1 (mitochondrial ribosomal pro-
tein L1), is shown in Fig. 6. Within this region, chr4:
79,148,707-79,148,858, we observed 73 overlapped RNA
fragments, whose distribution patterns are shown in Fig.
6B. It is clear that the enriched region contains more than
one protein binding site. A correlation coefficient matrix
was calculated, where each element (i, j) represents the
similarity of the distribution pattern between the experi-
mentally-detected fragments (Fig. 6B) and simulated frag-
ments by hypothetically assuming positions i and j being
the protein binding sites (Fig. 6C). The numbers in this
matrix are shown in Fig. 6D, where darker color implies
higher correlation coefficient. We observed higher correla-
tion coefficient in one sub-area in the matrix (blue framed
region in Fig. 6D), where iΕ[79148707,79148762] and
jΕ[79148789,79148799]. This implies that the two bind-
ing sites are probably located in this sub-area.
Effects of biological and computational variations on 
binding site prediction
To evaluate the robustness of the proposed approach to
various sources of experimental noises from both biolog-
ical and computational steps, we created a simulated set
of virtual amplicons by assuming known protein binding
sites and deliberately introducing three different types of
noise: antibody non-specificity, inaccurate estimation of
sequence specificity of RNase digestion, and blastn map-
ping errors.
a) Antibody non-specificity
Biological noise caused by antibody non-specificity may
potentially undermine the ability of the proposed
approach to accurately identify protein binding regions.
Within the genomic region that is enriched by the
detected RNA fragments, antibody non-specificity may
cause false detection of RNA fragments that are not really
Table 1: Top 1% 6-bp motifs and their RNase digestion frequencies
human transcriptome (entropy=0.96) detected RNA fragments (entropy=0.42) adjusted frequencies (entropy=0.56)
6-bp frequency 6-bp frequency 6-bp frequency
AAAAAA 0.0035 AATAAA 0.262 TCTACA 0.333
TTTTTT 0.0035 TCTACA 0.054 AATAAA 0.085
AAAAAT 0.0016 TTGAAT 0.033 TTGAAT 0.044
ATTTTT 0.0016 AACAGA 0.021 CCTACA 0.036
AAAATA 0.0015 AACAAG 0.019 AACAGA 0.024
TATTTT 0.0013 CCTACA 0.019 AACAAG 0.023
TAAAAA 0.0013 TCTGAA 0.018 TCTGAA 0.016
TTTTTA 0.0013 TTCAGA 0.014 TTCAGA 0.016
AAATAA 0.0013 ATTCTT 0.013 CGTGAA 0.011BMC Genomics 2008, 9(Suppl 1):S17 http://www.biomedcentral.com/1471-2164/9/S1/S17
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bound by the proteins. These fragments may or may not
encompass the real protein binding loci.
We tested the ability of the proposed approach to detect
the pre-defined protein binding site while introducing dif-
ferent levels of antibody non-specificity. Within a certain
genomic region, we composed a set of N virtual fragments
(50bp to 70bp) that were generated from two sources:
1. n fragments that appeared randomly within the region,
with no association with the pre-defined protein binding
site and no correlation with 6-bp motif composition of
local sequence. Hypothetically, these n fragments result
from antibody non-specificity.
2. N-n fragments that were simulated based on the 6-bp
motif composition of local sequence and pre-defined pro-
tein binding site. These N-n fragments simulate the
desired RNA fragments that associate with the studied
protein.
Genomic region that contains one protein binding site Figure 5
Genomic region that contains one protein binding site. A. Relative likelihood of RNase digestion at each genomic locus. 
B. Similarity between the distribution of experimentally-detected amplicons and simulated amplicons assuming protein binding 
occurs at the each locus. A higher correlation coefficient implies higher probability of protein binding. C. Distribution of 
detected RNA fragments. D. Distribution of simulated fragments based on the best prediction locus (marked as blue ellipse).BMC Genomics 2008, 9(Suppl 1):S17 http://www.biomedcentral.com/1471-2164/9/S1/S17
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Genomic region that contains two protein binding site Figure 6
Genomic region that contains two protein binding site. A. Relative likelihood of RNase digestion at each genomic 
locus. B. Distribution of detected RNA fragments. C. Distribution of simulated fragments based on the best prediction loci 
(marked as blue ellipse). D. Similarity between the distribution of experimentally-detected amplicons and simulated amplicons 
assuming that protein binding occurs at the each pair of genomic loci. The blue frame indicates the region where highest simi-
larity is observed (dark red).BMC Genomics 2008, 9(Suppl 1):S17 http://www.biomedcentral.com/1471-2164/9/S1/S17
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Fig. 7A demonstrated the correlation coefficient of the
number of RNA fragments that encompass each genomic
locus in a comparison between the fragments simulated
without noise (procedure 2) and the set combining the
simulated and random fragments in different propor-
tions. Not surprisingly, the correlation coefficient
decreases with the increase of the proportion of ran-
domly-added RNA fragments (n/N). It is clear, however,
that the proposed approach retains reasonably good
robustness against antibody non-specificity while the pro-
portion of detected RNA fragments contains less than
30% noise, with the correlation coefficient > 80%.
b) Inaccurate estimation of sequence specificity of RNase
digestion.
The inaccurate estimation of the sequence specificity of
RNase digestion may potentially decrease the accuracy of
the model prediction. In this step, we deliberately added
measurement noise to the estimated likelihood of RNase
digestion on each 6-bp motif and tested the ability of the
proposed approach to recover the pre-defined protein
binding site. The correlation coefficient of the sequence
frequency (number of RNA fragments that encompass
each genomic locus) between RNA fragments simulated
with and without added noise are shown in Fig. 7B. The
accuracy of the model dropped rapidly with the increase
of estimation noise of RNase digestion. Therefore, an
accurate estimation of the RNase sequence preference is a
crucial step in the proposed approach.
c) Noise from BLAST
Mapping the detected fragment back to human transcrip-
tome using blastn is not always accurate. This is in part due
to the sequencing error in the experimental stage, or due
to the blastn parameters used. The consequences of BLAST
noise on the model prediction are similar to the predic-
tion inaccuracy caused by the antibody non-specificity,
i.e. RNA fragments are inaccurately assigned to the studied
genomic region. These RNA fragments usually have no
association with the real protein binding sites, and have
no correlation with the 6-bp motif composition of the
studied genomic region. The effect of such noise on the
model prediction is evaluated in the Fig. 7A. The model
was robust against the noise resulted from BLAST inaccu-
racy.
Discussion
In this study, we propose a computational approach to
refine the detection of protein binding regions from pyro-
sequencing-derived RNA fragments. As an ultra-high-
throughput technology, pyro-sequencing allows sequenc-
ing of more than 100,000 amplicons in a single experi-
ment [10]. Combined with antibody-based technologies
such as chromatin immunoprecipitation (ChIP) or cross-
linking immunoprecipitation (CLIP), this technology
provides a great opportunity for the researchers to identify
de novo binding regions of DNA/RNA binding proteins in
a genome-wide scale.
Using pyro-CLIP experiment as an example, we present a
computational framework to increase the detection reso-
lution within an RNA-fragment-enriched region by using
(1) the distribution patterns of the detected amplicons
(Fig. 1B, 2A, 5C and 6B), and (2) the sequence specificity
of RNase digestion along the local genomic sequences of
the enriched region.
Multiple RNA fragments can be detected in each enriched
region. Intuitively, protein binding region can be local-
Effects of computational and biological variations on  binding site prediction Figure 7
Effects of computational and biological variations on 
binding site prediction. A. Robustness of binding site pre-
diction on antibody non-specificity and blastn inaccuracy. B. 
Robustness of binding site prediction on the inaccurate esti-
mation of sequence specificity of RNase digestion.Publish with BioMed Central    and   every 
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ized by finding the common genomic regions that are
encompassed by all the local fragments. This is based on
the assumption that only those RNA fragments that con-
tain the protein binding site can be immunoprecipated by
the antibody, and therefore can be detected by the system.
Localization is compromised by the sequence selectivity
of RNase digestion. Therefore, the distribution pattern of
the RNA fragments contains less information than the one
that would result from random sequence cutting. Incorpo-
rating the sequence preference of the RNase digestion into
the model can partially recover the information. In con-
clusion, the proposed approach demonstrated great
potential in refining the detection of protein binding
region using pyrosequencing-derived RNA fragments.
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